|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.40 CNY | -1.55% |
|
-0.92% | +4.43% |
| 04-24 | Dashenlin Pharma's Q1 Profit Rises 11% | MT |
| 04-24 | Dashenlin Pharma's 2025 Profit Jumps 35%, Revenue Rises 4% | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 4.9% | 5.4% | 14.12x | 2.64x | 0.58x | 4.64x | 7.65x | 3.09B | |
| -.--% | -.--% | 17.39x | 1.53x | 0.72x | 11.3x | 12.13x | 15.05B | |
| 1% | 1.24% | 22.77x | 2.52x | 0.9x | 15.82x | 16.07x | 6.88B | |
| 2.31% | 2.63% | 16.12x | 1.7x | 0.72x | 7.52x | 9.46x | 5.91B | |
| 3.11% | 3.43% | 13.78x | 2.07x | 0.88x | 6.37x | 8.34x | 3.9B | |
| 5.48% | 6.23% | 13.96x | 4.27x | 1.19x | 7.29x | 13.71x | 3.16B | |
| 4.39% | 4.81% | 14.62x | 6.61x | 0.88x | 6.64x | 9.23x | 2.96B | |
| 1.95% | 2.36% | 21.12x | 3.7x | 0.61x | 7.84x | 12.84x | 1.51B | |
| 0.01% | -.--% | -91.83x | 2.89x | 0.46x | 17.01x | 103.36x | 1.51B | |
| 4.33% | 4.88% | 11.72x | 0.84x | 0.27x | 2.67x | 5.51x | 928M | |
| 5.79% | 5.6% | 14.44x | 2.39x | 0.85x | 6.89x | 14.83x | 915M | |
| 1.38% | 2.01% | 25.87x | 7.05x | 0.94x | 12.77x | 19.79x | 776M | |
| 0.36% | 0.37% | 14.5x | 1.96x | 0.69x | 8.48x | 13.7x | 705M | |
| Average | 2.69% | 3% | 8.35x | 3.09x | 0.75x | 8.86x | 18.97x | 3.64B | |
| Weighted average by Cap. | 1.94% | 2.18% | 13.66x | 2.53x | 0.78x | 9.88x | 14.70x |
Select your edition
All financial news and data tailored to specific country editions
